We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.05B
AUM Growth
+$503M
Cap. Flow
+$454M
Cap. Flow %
11.2%
Top 10 Hldgs %
55.84%
Holding
654
New
120
Increased
131
Reduced
191
Closed
155

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$269M
2
SRCL
Stericycle Inc
SRCL
+$141M
3
MRO
Marathon Oil Corporation
MRO
+$108M
4
CHX
ChampionX
CHX
+$103M
5
SPR
Spirit AeroSystems
SPR
+$95.3M

Top Sells

Rank Stock Value
1
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$149M
2
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$81.8M
3
SWN
Southwestern Energy Company
SWN
+$56.7M
4
UNP icon
Union Pacific
UNP
+$24.2M
5
X
US Steel
X
+$20.2M

Sector Composition

Rank Sector Weight
1 Energy 20.91%
2 Technology 19.62%
3 Healthcare 14.36%
4 Industrials 11.13%
5 Consumer Staples 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CATX icon
276
Perspective Therapeutics
CATX
$339M
$947K 0.02%
70,923
-14,090
-17% -$187K
AGIO icon
277
Agios Pharmaceuticals
AGIO
$1.91B
$937K 0.02%
21,087
-8,926
-30% -$405K
PODD icon
278
Insulet
PODD
$9.66B
$936K 0.02%
4,021
+374
+10% +$76.8K
LION icon
279
Lionsgate Studios
LION
$3.85B
$935K 0.02%
130,774
-19,226
-13% -$142K
KALA icon
280
KALA BIO
KALA
$14.2M
$927K 0.02%
3,253
+302
+10% +$95.3K
COO icon
281
Cooper Companies
COO
$14.3B
$914K 0.02%
8,286
+2,997
+57% +$292K
SWTX
282
DELISTED
SpringWorks Therapeutics
SWTX
$914K 0.02%
28,513
-3,701
-11% -$138K
ATEC icon
283
Alphatec Holdings
ATEC
$1.42B
$902K 0.02%
162,297
+58,526
+56% +$449K
TGTX icon
284
TG Therapeutics
TGTX
$7.58B
$899K 0.02%
+38,417
New +$839K
DNLI icon
285
Denali Therapeutics
DNLI
$3.92B
$896K 0.02%
30,744
-773
-2% -$19.2K
ARQT icon
286
Arcutis Biotherapeutics
ARQT
$3.32B
$856K 0.02%
+92,019
New +$908K
ADPT icon
287
Adaptive Biotechnologies
ADPT
$3.75B
$846K 0.02%
165,274
+99,529
+151% +$434K
BCYC
288
Bicycle Therapeutics
BCYC
$278M
$814K 0.02%
35,976
-51,084
-59% -$1.18M
SLRN
289
DELISTED
ACELYRIN
SLRN
$807K 0.02%
163,724
+82,312
+101% +$425K
MLTX icon
290
MoonLake Immunotherapeutics
MLTX
$1.53B
$807K 0.02%
+16,000
New +$750K
SPY icon
291
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$818B
$799K 0.02%
115,000
+15,000
+15% +$8.29M
RLAY icon
292
Relay Therapeutics
RLAY
$4.3B
$793K 0.02%
+112,048
New +$837K
GPCR icon
293
Structure Therapeutics
GPCR
$3.74B
$790K 0.02%
+18,000
New +$696K
SLNO
294
DELISTED
Soleno Therapeutics
SLNO
$784K 0.02%
15,536
+536
+4% +$25.7K
SYRS
295
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$773K 0.02%
359,305
+81,202
+29% +$292K
CGEM icon
296
Cullinan Oncology
CGEM
$1.16B
$770K 0.02%
45,975
-16,000
-26% -$284K
DHI icon
297
D.R. Horton
DHI
$40.8B
$759K 0.02%
3,978
-40,275
-91% -$7.08M
BLCO icon
298
Bausch + Lomb
BLCO
$5.84B
$752K 0.02%
+39,000
New +$645K
OVID icon
299
Ovid Therapeutics
OVID
$495M
$741K 0.02%
628,290
+340,000
+118% +$355K
ON icon
300
ON Semiconductor
ON
$18.6B
$726K 0.02%
10,000
-5,000
-33% -$364K
10 11
12
13 14

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q3 2024 Portfolio in Review

As of Q3 2024, UBS O'Connor held 654 positions worth $4.05B, up 14% from $3.55B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $454M of net new capital in Q3 2024, opening 120 new positions and adding to 131 existing holdings. Its largest new stake was Kellanova: 3,778,689 shares worth $305M.

By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was US Steel, an estimated $20.2M trimmed.

  • UBS O'Connor's largest Q3 2024 buy was Kellanova: 3,778,689 shares worth $305M.
  • UBS O'Connor added most to Stericycle Inc in Q3 2024, an estimated $141M increase.
  • UBS O'Connor's biggest Q3 2024 reduction was US Steel, cutting an estimated $20.2M.
  • UBS O'Connor fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $149M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.05B portfolio in Q3 2024.
  • UBS O'Connor opened 120 new positions and closed 155 in Q3 2024.
  • UBS O'Connor's portfolio value rose 14% quarter-over-quarter to $4.05B.

Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.